Home > DARE Reviews > Vandetanib plus docetaxel versus...
  • We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews.

Vandetanib plus docetaxel versus docetaxel for advanced non-small cell lung cancer: a meta-analysis

Review published: 2011.

Bibliographic details: Wang MC, Yang JL, Gao TM.  Vandetanib plus docetaxel versus docetaxel for advanced non-small cell lung cancer: a meta-analysis. Chinese Journal of Evidence-Based Medicine 2011; 11(10): 1151-1155. Available from: http://www.cjebm.org.cn/oa/DArticle.aspx?type=view&id=201110011

CRD has determined that this article meets the DARE scientific quality criteria for a systematic review.

Copyright © 2014 University of York.

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...